source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[individual]	characteristics[twin pair]	characteristics[twin type]	characteristics[developmental stage]	characteristics[disease]	characteristics[menopausal stage]	characteristics[depletion]	characteristics[depletion method]	characteristics[biological replicate]	assay name	Technology type	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[proteomics data acquisition method]	comment[label]	comment[technical replicate]	comment[cleavage agent details]	comment[instrument]	comment[separation]	comment[modification parameters]	comment[modification parameters]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[organism part]
PXD001064-Sample-1	Homo sapiens	blood plasma	not applicable	not applicable	61	female	1	1	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	1	run 1	proteomic profiling by mass spectrometry	yanliu_L130124_009_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_009_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-2	Homo sapiens	blood plasma	not applicable	not applicable	68	female	1	1	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	1	run 2	proteomic profiling by mass spectrometry	yanliu_L130319_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_004_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-3	Homo sapiens	blood plasma	not applicable	not applicable	61	female	2	1	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	2	run 3	proteomic profiling by mass spectrometry	yanliu_L130124_010_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_010_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-4	Homo sapiens	blood plasma	not applicable	not applicable	68	female	2	1	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	2	run 4	proteomic profiling by mass spectrometry	yanliu_L130319_007_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_007_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-5	Homo sapiens	blood plasma	not applicable	not applicable	41	female	3	2	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	3	run 5	proteomic profiling by mass spectrometry	yanliu_L130211_001_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_001_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-6	Homo sapiens	blood plasma	not applicable	not applicable	47	female	3	2	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	3	run 6	proteomic profiling by mass spectrometry	yanliu_L130109_036_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_036_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-7	Homo sapiens	blood plasma	not applicable	not applicable	41	female	4	2	monozygotic	not applicable	normal	"Going through menopause at visit 1, Going through menopause or Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	4	run 7	proteomic profiling by mass spectrometry	yanliu_L130211_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_002_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-8	Homo sapiens	blood plasma	not applicable	not applicable	47	female	4	2	monozygotic	not applicable	normal	"Going through menopause at visit 1, Going through menopause or Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	4	run 8	proteomic profiling by mass spectrometry	yanliu_L130109_037_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_037_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-9	Homo sapiens	blood plasma	not applicable	not applicable	50	female	5	3	monozygotic	not applicable	normal	"Pre menopausal at visit 1, Going through menopause or Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	5	run 9	proteomic profiling by mass spectrometry	yanliu_L130109_026_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_026_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-10	Homo sapiens	blood plasma	not applicable	not applicable	55	female	5	3	monozygotic	not applicable	normal	"Pre menopausal at visit 1, Going through menopause or Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	5	run 10	proteomic profiling by mass spectrometry	yanliu_L130313_035_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_035_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-11	Homo sapiens	blood plasma	not applicable	not applicable	50	female	6	3	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	6	run 11	proteomic profiling by mass spectrometry	yanliu_L130211_013_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_013_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-12	Homo sapiens	blood plasma	not applicable	not applicable	55	female	6	3	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	6	run 12	proteomic profiling by mass spectrometry	yanliu_L130313_036_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_036_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-13	Homo sapiens	blood plasma	not applicable	not applicable	64	female	7	4	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	7	run 13	proteomic profiling by mass spectrometry	yanliu_L130313_018_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_018_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-14	Homo sapiens	blood plasma	not applicable	not applicable	70	female	7	4	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	7	run 14	proteomic profiling by mass spectrometry	yanliu_L130124_020_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_020_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-15	Homo sapiens	blood plasma	not applicable	not applicable	64	female	8	4	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	8	run 15	proteomic profiling by mass spectrometry	yanliu_L130313_021_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_021_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-16	Homo sapiens	blood plasma	not applicable	not applicable	70	female	8	4	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	8	run 16	proteomic profiling by mass spectrometry	yanliu_L130308_022_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_022_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-17	Homo sapiens	blood plasma	not applicable	not applicable	74	female	9	5	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	9	run 17	proteomic profiling by mass spectrometry	yanliu_L130116_015_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_015_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-18	Homo sapiens	blood plasma	not applicable	not applicable	77	female	9	5	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	9	run 18	proteomic profiling by mass spectrometry	yanliu_L130116_012_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_012_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-19	Homo sapiens	blood plasma	not applicable	not applicable	74	female	10	5	monozygotic	not applicable	normal	N.A. at visit 1 & Post menopausal at visit 2	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	10	run 19	proteomic profiling by mass spectrometry	yanliu_L130116_018_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_018_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-20	Homo sapiens	blood plasma	not applicable	not applicable	77	female	10	5	monozygotic	not applicable	normal	N.A. at visit 1 & Post menopausal at visit 2	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	10	run 20	proteomic profiling by mass spectrometry	yanliu_L130116_013_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_013_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-21	Homo sapiens	blood plasma	not applicable	not applicable	60	female	11	6	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	11	run 21	proteomic profiling by mass spectrometry	yanliu_L130308_018_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_018_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-22	Homo sapiens	blood plasma	not applicable	not applicable	61	female	11	6	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	11	run 22	proteomic profiling by mass spectrometry	yanliu_L130109_018_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_018_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-23	Homo sapiens	blood plasma	not applicable	not applicable	60	female	12	6	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	12	run 23	proteomic profiling by mass spectrometry	yanliu_L130308_019_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_019_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-24	Homo sapiens	blood plasma	not applicable	not applicable	61	female	12	6	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	12	run 24	proteomic profiling by mass spectrometry	yanliu_L130109_019_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_019_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-25	Homo sapiens	blood plasma	not applicable	not applicable	56	female	13	7	monozygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	13	run 25	proteomic profiling by mass spectrometry	yanliu_L130313_001_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_001_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-26	Homo sapiens	blood plasma	not applicable	not applicable	62	female	13	7	monozygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	13	run 26	proteomic profiling by mass spectrometry	yanliu_L130313_031_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_031_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-27	Homo sapiens	blood plasma	not applicable	not applicable	56	female	14	7	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	14	run 27	proteomic profiling by mass spectrometry	yanliu_L130313_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_002_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-28	Homo sapiens	blood plasma	not applicable	not applicable	62	female	14	7	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	14	run 28	proteomic profiling by mass spectrometry	yanliu_L130313_032_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_032_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-29	Homo sapiens	blood plasma	not applicable	not applicable	43	female	15	8	monozygotic	not applicable	normal	"Pre menopausal at visit 1, Going through menopause or Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	15	run 29	proteomic profiling by mass spectrometry	yanliu_L130313_009_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_009_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-30	Homo sapiens	blood plasma	not applicable	not applicable	49	female	15	8	monozygotic	not applicable	normal	"Pre menopausal at visit 1, Going through menopause or Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	15	run 30	proteomic profiling by mass spectrometry	yanliu_L130313_011_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_011_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-31	Homo sapiens	blood plasma	not applicable	not applicable	43	female	16	8	monozygotic	not applicable	normal	"Going through menopause at visit 1, Going through menopause or Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	16	run 31	proteomic profiling by mass spectrometry	yanliu_L130313_010_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_010_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-32	Homo sapiens	blood plasma	not applicable	not applicable	49	female	16	8	monozygotic	not applicable	normal	"Going through menopause at visit 1, Going through menopause or Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	16	run 32	proteomic profiling by mass spectrometry	yanliu_L130313_012_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_012_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-33	Homo sapiens	blood plasma	not applicable	not applicable	38	female	17	9	dizygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	17	run 33	proteomic profiling by mass spectrometry	yanliu_L130220_007_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130220_007_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-34	Homo sapiens	blood plasma	not applicable	not applicable	44	female	17	9	dizygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	17	run 34	proteomic profiling by mass spectrometry	yanliu_L130220_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130220_002_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-35	Homo sapiens	blood plasma	not applicable	not applicable	38	female	18	9	dizygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	18	run 35	proteomic profiling by mass spectrometry	yanliu_L130220_008_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130220_008_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-36	Homo sapiens	blood plasma	not applicable	not applicable	44	female	18	9	dizygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	18	run 36	proteomic profiling by mass spectrometry	yanliu_L130220_010_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130220_010_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-37	Homo sapiens	blood plasma	not applicable	not applicable	65	female	19	10	dizygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	19	run 37	proteomic profiling by mass spectrometry	yanliu_L130503_001_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130503_001_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-38	Homo sapiens	blood plasma	not applicable	not applicable	68	female	19	10	dizygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	19	run 38	proteomic profiling by mass spectrometry	yanliu_L130313_024_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_024_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-39	Homo sapiens	blood plasma	not applicable	not applicable	65	female	20	10	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	20	run 39	proteomic profiling by mass spectrometry	yanliu_L130124_007_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_007_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-40	Homo sapiens	blood plasma	not applicable	not applicable	68	female	20	10	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	20	run 40	proteomic profiling by mass spectrometry	yanliu_L130109_024_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_024_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-41	Homo sapiens	blood plasma	not applicable	not applicable	62	female	21	11	dizygotic	not applicable	normal	"Going through menopause at visit 1, Going through menopause or Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	21	run 41	proteomic profiling by mass spectrometry	yanliu_L130211_009_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_009_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-42	Homo sapiens	blood plasma	not applicable	not applicable	68	female	21	11	dizygotic	not applicable	normal	"Going through menopause at visit 1, Going through menopause or Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	21	run 42	proteomic profiling by mass spectrometry	yanliu_L130109_020_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_020_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-43	Homo sapiens	blood plasma	not applicable	not applicable	62	female	22	11	dizygotic	not applicable	normal	"Going through menopause at visit 1, N.A. at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	22	run 43	proteomic profiling by mass spectrometry	yanliu_L130211_010_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_010_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-44	Homo sapiens	blood plasma	not applicable	not applicable	68	female	22	11	dizygotic	not applicable	normal	"Going through menopause at visit 1, N.A. at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	22	run 44	proteomic profiling by mass spectrometry	yanliu_L130109_021_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_021_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-45	Homo sapiens	blood plasma	not applicable	not applicable	59	female	23	12	dizygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	23	run 45	proteomic profiling by mass spectrometry	yanliu_L130220_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130220_004_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-46	Homo sapiens	blood plasma	not applicable	not applicable	64	female	23	12	dizygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	23	run 46	proteomic profiling by mass spectrometry	yanliu_L130211_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_003_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-47	Homo sapiens	blood plasma	not applicable	not applicable	59	female	24	12	dizygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	24	run 47	proteomic profiling by mass spectrometry	yanliu_L130116_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_005_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-48	Homo sapiens	blood plasma	not applicable	not applicable	64	female	24	12	dizygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	24	run 48	proteomic profiling by mass spectrometry	yanliu_L130211_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_004_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-49	Homo sapiens	blood plasma	not applicable	not applicable	58	female	25	13	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	25	run 49	proteomic profiling by mass spectrometry	yanliu_L130109_035_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_035_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-50	Homo sapiens	blood plasma	not applicable	not applicable	62	female	25	13	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	25	run 50	proteomic profiling by mass spectrometry	yanliu_L130124_016_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_016_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-51	Homo sapiens	blood plasma	not applicable	not applicable	58	female	26	13	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	26	run 51	proteomic profiling by mass spectrometry	yanliu_L130211_021_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_021_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-52	Homo sapiens	blood plasma	not applicable	not applicable	62	female	26	13	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	26	run 52	proteomic profiling by mass spectrometry	yanliu_L130124_017_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_017_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-53	Homo sapiens	blood plasma	not applicable	not applicable	52	female	27	14	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	27	run 53	proteomic profiling by mass spectrometry	yanliu_L130308_025_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_025_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-54	Homo sapiens	blood plasma	not applicable	not applicable	58	female	27	14	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	27	run 54	proteomic profiling by mass spectrometry	yanliu_L130308_027_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_027_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-55	Homo sapiens	blood plasma	not applicable	not applicable	52	female	28	14	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	28	run 55	proteomic profiling by mass spectrometry	yanliu_L130308_028_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_028_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-56	Homo sapiens	blood plasma	not applicable	not applicable	58	female	28	14	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	28	run 56	proteomic profiling by mass spectrometry	yanliu_L130308_030_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_030_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-57	Homo sapiens	blood plasma	not applicable	not applicable	58	female	29	15	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	29	run 57	proteomic profiling by mass spectrometry	yanliu_L130308_032_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_032_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-58	Homo sapiens	blood plasma	not applicable	not applicable	46	female	29	15	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	29	run 58	proteomic profiling by mass spectrometry	yanliu_L130319_014_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_014_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-59	Homo sapiens	blood plasma	not applicable	not applicable	54	female	30	15	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	30	run 59	proteomic profiling by mass spectrometry	yanliu_L130109_010_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_010_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-60	Homo sapiens	blood plasma	not applicable	not applicable	46	female	30	15	dizygotic	not applicable	normal	"Pre menopausal at visit 1, Going through menopause or Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	30	run 60	proteomic profiling by mass spectrometry	yanliu_L130104_011_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_011_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-61	Homo sapiens	blood plasma	not applicable	not applicable	54	female	31	16	dizygotic	not applicable	normal	"Pre menopausal at visit 1, Going through menopause or Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	31	run 61	proteomic profiling by mass spectrometry	yanliu_L130109_011_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_011_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-62	Homo sapiens	blood plasma	not applicable	not applicable	66	female	31	16	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	31	run 62	proteomic profiling by mass spectrometry	yanliu_L130308_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_004_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-63	Homo sapiens	blood plasma	not applicable	not applicable	70	female	32	16	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	32	run 63	proteomic profiling by mass spectrometry	yanliu_L130124_001_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_001_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-64	Homo sapiens	blood plasma	not applicable	not applicable	66	female	32	16	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	32	run 64	proteomic profiling by mass spectrometry	yanliu_L130308_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_005_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-65	Homo sapiens	blood plasma	not applicable	not applicable	70	female	33	17	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	33	run 65	proteomic profiling by mass spectrometry	yanliu_L130220_013_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130220_013_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-66	Homo sapiens	blood plasma	not applicable	not applicable	48	female	33	17	dizygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	33	run 66	proteomic profiling by mass spectrometry	yanliu_L130104_018_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_018_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-67	Homo sapiens	blood plasma	not applicable	not applicable	56	female	34	17	dizygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	34	run 67	proteomic profiling by mass spectrometry	yanliu_L130319_008_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_008_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-68	Homo sapiens	blood plasma	not applicable	not applicable	48	female	34	17	dizygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	34	run 68	proteomic profiling by mass spectrometry	yanliu_L130124_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_005_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-69	Homo sapiens	blood plasma	not applicable	not applicable	56	female	35	18	dizygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	35	run 69	proteomic profiling by mass spectrometry	yanliu_L130319_011_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_011_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-70	Homo sapiens	blood plasma	not applicable	not applicable	60	female	35	18	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	35	run 70	proteomic profiling by mass spectrometry	yanliu_L130109_023_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_023_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-71	Homo sapiens	blood plasma	not applicable	not applicable	66	female	36	18	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	36	run 71	proteomic profiling by mass spectrometry	yanliu_L130313_007_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_007_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-72	Homo sapiens	blood plasma	not applicable	not applicable	61	female	36	18	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	36	run 72	proteomic profiling by mass spectrometry	yanliu_L130109_032_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_032_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-73	Homo sapiens	blood plasma	not applicable	not applicable	66	female	37	19	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	37	run 73	proteomic profiling by mass spectrometry	yanliu_L130313_008_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_008_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-74	Homo sapiens	blood plasma	not applicable	not applicable	59	female	37	19	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	37	run 74	proteomic profiling by mass spectrometry	yanliu_L130308_021_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_021_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-75	Homo sapiens	blood plasma	not applicable	not applicable	65	female	38	19	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	38	run 75	proteomic profiling by mass spectrometry	yanliu_L130313_027_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_027_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-76	Homo sapiens	blood plasma	not applicable	not applicable	59	female	38	19	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	38	run 76	proteomic profiling by mass spectrometry	yanliu_L130308_024_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_024_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-77	Homo sapiens	blood plasma	not applicable	not applicable	65	female	39	20	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	39	run 77	proteomic profiling by mass spectrometry	yanliu_L130313_028_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_028_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-78	Homo sapiens	blood plasma	not applicable	not applicable	52	female	39	20	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	39	run 78	proteomic profiling by mass spectrometry	yanliu_L130104_031_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_031_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-79	Homo sapiens	blood plasma	not applicable	not applicable	58	female	40	20	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	40	run 79	proteomic profiling by mass spectrometry	yanliu_L130308_023_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_023_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-80	Homo sapiens	blood plasma	not applicable	not applicable	52	female	40	20	monozygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	40	run 80	proteomic profiling by mass spectrometry	yanliu_L130124_018_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_018_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-81	Homo sapiens	blood plasma	not applicable	not applicable	58	female	41	21	monozygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	41	run 81	proteomic profiling by mass spectrometry	yanliu_L130308_026_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_026_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-82	Homo sapiens	blood plasma	not applicable	not applicable	72	female	41	21	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	41	run 82	proteomic profiling by mass spectrometry	yanliu_L130104_017_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_017_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-83	Homo sapiens	blood plasma	not applicable	not applicable	76	female	42	21	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	42	run 83	proteomic profiling by mass spectrometry	yanliu_L130104_009_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_009_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-84	Homo sapiens	blood plasma	not applicable	not applicable	72	female	42	21	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	42	run 84	proteomic profiling by mass spectrometry	yanliu_L130116_014_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_014_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-85	Homo sapiens	blood plasma	not applicable	not applicable	76	female	43	22	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	43	run 85	proteomic profiling by mass spectrometry	yanliu_L130104_010_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_010_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-86	Homo sapiens	blood plasma	not applicable	not applicable	52	female	43	22	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	43	run 86	proteomic profiling by mass spectrometry	yanliu_L130313_034_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_034_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-87	Homo sapiens	blood plasma	not applicable	not applicable	57	female	44	22	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	44	run 87	proteomic profiling by mass spectrometry	yanliu_L130109_025_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_025_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-88	Homo sapiens	blood plasma	not applicable	not applicable	52	female	44	22	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	44	run 88	proteomic profiling by mass spectrometry	yanliu_L130109_031_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_031_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-89	Homo sapiens	blood plasma	not applicable	not applicable	57	female	45	23	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	45	run 89	proteomic profiling by mass spectrometry	yanliu_L130211_011_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_011_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-90	Homo sapiens	blood plasma	not applicable	not applicable	50	female	45	23	monozygotic	not applicable	normal	"Pre menopausal at visit 1, Going through menopause or Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	45	run 90	proteomic profiling by mass spectrometry	yanliu_L130313_030_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_030_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-91	Homo sapiens	blood plasma	not applicable	not applicable	55	female	46	23	monozygotic	not applicable	normal	"Pre menopausal at visit 1, Going through menopause or Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	46	run 91	proteomic profiling by mass spectrometry	yanliu_L130109_009_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_009_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-92	Homo sapiens	blood plasma	not applicable	not applicable	50	female	46	23	monozygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	46	run 92	proteomic profiling by mass spectrometry	yanliu_L130313_033_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_033_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-93	Homo sapiens	blood plasma	not applicable	not applicable	55	female	47	24	monozygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	47	run 93	proteomic profiling by mass spectrometry	yanliu_L130124_028_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_028_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-94	Homo sapiens	blood plasma	not applicable	not applicable	60	female	47	24	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	47	run 94	proteomic profiling by mass spectrometry	yanliu_L130116_016_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_016_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-95	Homo sapiens	blood plasma	not applicable	not applicable	65	female	48	24	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	48	run 95	proteomic profiling by mass spectrometry	yanliu_L130220_001_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130220_001_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-96	Homo sapiens	blood plasma	not applicable	not applicable	60	female	48	24	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	48	run 96	proteomic profiling by mass spectrometry	yanliu_L130116_017_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_017_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-97	Homo sapiens	blood plasma	not applicable	not applicable	65	female	49	25	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	49	run 97	proteomic profiling by mass spectrometry	yanliu_L130319_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_003_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-98	Homo sapiens	blood plasma	not applicable	not applicable	61	female	49	25	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	49	run 98	proteomic profiling by mass spectrometry	yanliu_L130104_023_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_023_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-99	Homo sapiens	blood plasma	not applicable	not applicable	63	female	50	25	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	50	run 99	proteomic profiling by mass spectrometry	yanliu_L130211_019_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_019_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-100	Homo sapiens	blood plasma	not applicable	not applicable	61	female	50	25	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	50	run 100	proteomic profiling by mass spectrometry	yanliu_L130124_011_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_011_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-101	Homo sapiens	blood plasma	not applicable	not applicable	63	female	51	26	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	51	run 101	proteomic profiling by mass spectrometry	yanliu_L130211_020_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_020_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-102	Homo sapiens	blood plasma	not applicable	not applicable	57	female	51	26	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	51	run 102	proteomic profiling by mass spectrometry	yanliu_L130116_020_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_020_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-103	Homo sapiens	blood plasma	not applicable	not applicable	62	female	52	26	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	52	run 103	proteomic profiling by mass spectrometry	yanliu_L130124_021_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_021_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-104	Homo sapiens	blood plasma	not applicable	not applicable	57	female	52	26	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	52	run 104	proteomic profiling by mass spectrometry	yanliu_L130116_021_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_021_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-105	Homo sapiens	blood plasma	not applicable	not applicable	62	female	53	27	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	53	run 105	proteomic profiling by mass spectrometry	yanliu_L130124_029_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_029_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-106	Homo sapiens	blood plasma	not applicable	not applicable	61	female	53	27	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	53	run 106	proteomic profiling by mass spectrometry	yanliu_L130220_015_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130220_015_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-107	Homo sapiens	blood plasma	not applicable	not applicable	65	female	54	27	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	54	run 107	proteomic profiling by mass spectrometry	yanliu_L130319_015_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_015_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-108	Homo sapiens	blood plasma	not applicable	not applicable	61	female	54	27	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	54	run 108	proteomic profiling by mass spectrometry	yanliu_L130308_001_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_001_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-109	Homo sapiens	blood plasma	not applicable	not applicable	65	female	55	28	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	55	run 109	proteomic profiling by mass spectrometry	yanliu_L130116_025_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_025_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-110	Homo sapiens	blood plasma	not applicable	not applicable	68	female	55	28	dizygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	55	run 110	proteomic profiling by mass spectrometry	yanliu_L130104_027_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_027_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-111	Homo sapiens	blood plasma	not applicable	not applicable	74	female	56	28	dizygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	56	run 111	proteomic profiling by mass spectrometry	yanliu_L130109_028_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_028_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-112	Homo sapiens	blood plasma	not applicable	not applicable	68	female	56	28	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	56	run 112	proteomic profiling by mass spectrometry	yanliu_L130104_028_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_028_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-113	Homo sapiens	blood plasma	not applicable	not applicable	74	female	57	29	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	57	run 113	proteomic profiling by mass spectrometry	yanliu_L130211_015_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_015_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-114	Homo sapiens	blood plasma	not applicable	not applicable	54	female	57	29	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	57	run 114	proteomic profiling by mass spectrometry	yanliu_L130124_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_006_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-115	Homo sapiens	blood plasma	not applicable	not applicable	58	female	58	29	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	58	run 115	proteomic profiling by mass spectrometry	yanliu_L130124_008_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_008_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-116	Homo sapiens	blood plasma	not applicable	not applicable	54	female	58	29	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	58	run 116	proteomic profiling by mass spectrometry	yanliu_L130104_021_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_021_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-117	Homo sapiens	blood plasma	not applicable	not applicable	58	female	59	30	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	59	run 117	proteomic profiling by mass spectrometry	yanliu_L130104_022_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_022_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-118	Homo sapiens	blood plasma	not applicable	not applicable	59	female	59	30	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	59	run 118	proteomic profiling by mass spectrometry	yanliu_L130104_008_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_008_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-119	Homo sapiens	blood plasma	not applicable	not applicable	63	female	60	30	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	60	run 119	proteomic profiling by mass spectrometry	yanliu_L130104_012_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_012_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-120	Homo sapiens	blood plasma	not applicable	not applicable	59	female	60	30	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	60	run 120	proteomic profiling by mass spectrometry	yanliu_L130319_013_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_013_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-121	Homo sapiens	blood plasma	not applicable	not applicable	63	female	61	31	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	61	run 121	proteomic profiling by mass spectrometry	yanliu_L130104_013_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_013_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-122	Homo sapiens	blood plasma	not applicable	not applicable	61	female	61	31	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	61	run 122	proteomic profiling by mass spectrometry	yanliu_L130319_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_002_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-123	Homo sapiens	blood plasma	not applicable	not applicable	64	female	62	31	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	62	run 123	proteomic profiling by mass spectrometry	yanliu_L130308_010_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_010_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-124	Homo sapiens	blood plasma	not applicable	not applicable	61	female	62	31	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	62	run 124	proteomic profiling by mass spectrometry	yanliu_L130319_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_005_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-125	Homo sapiens	blood plasma	not applicable	not applicable	64	female	63	32	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	63	run 125	proteomic profiling by mass spectrometry	yanliu_L130308_011_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_011_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-126	Homo sapiens	blood plasma	not applicable	not applicable	58	female	63	32	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	63	run 126	proteomic profiling by mass spectrometry	yanliu_L130124_014_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_014_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-127	Homo sapiens	blood plasma	not applicable	not applicable	64	female	64	32	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	64	run 127	proteomic profiling by mass spectrometry	yanliu_L130313_020_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_020_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-128	Homo sapiens	blood plasma	not applicable	not applicable	58	female	64	32	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	64	run 128	proteomic profiling by mass spectrometry	yanliu_L130124_015_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_015_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-129	Homo sapiens	blood plasma	not applicable	not applicable	64	female	65	33	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	65	run 129	proteomic profiling by mass spectrometry	yanliu_L130313_023_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_023_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-130	Homo sapiens	blood plasma	not applicable	not applicable	61	female	65	33	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	65	run 130	proteomic profiling by mass spectrometry	yanliu_L130319_010_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_010_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-131	Homo sapiens	blood plasma	not applicable	not applicable	67	female	66	33	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	66	run 131	proteomic profiling by mass spectrometry	yanliu_L130116_008_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_008_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-132	Homo sapiens	blood plasma	not applicable	not applicable	61	female	66	33	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	66	run 132	proteomic profiling by mass spectrometry	yanliu_L130116_001_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_001_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-133	Homo sapiens	blood plasma	not applicable	not applicable	67	female	67	34	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	67	run 133	proteomic profiling by mass spectrometry	yanliu_L130116_009_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_009_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-134	Homo sapiens	blood plasma	not applicable	not applicable	55	female	67	34	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	67	run 134	proteomic profiling by mass spectrometry	yanliu_L130116_026_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_026_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-135	Homo sapiens	blood plasma	not applicable	not applicable	63	female	68	34	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	68	run 135	proteomic profiling by mass spectrometry	yanliu_L130104_014_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_014_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-136	Homo sapiens	blood plasma	not applicable	not applicable	55	female	68	34	dizygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	68	run 136	proteomic profiling by mass spectrometry	yanliu_L130116_027_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_027_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-137	Homo sapiens	blood plasma	not applicable	not applicable	63	female	69	35	dizygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	69	run 137	proteomic profiling by mass spectrometry	yanliu_L130104_015_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_015_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-138	Homo sapiens	blood plasma	not applicable	not applicable	72	female	69	35	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	69	run 138	proteomic profiling by mass spectrometry	yanliu_L130308_029_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_029_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-139	Homo sapiens	blood plasma	not applicable	not applicable	75	female	70	35	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	70	run 139	proteomic profiling by mass spectrometry	yanliu_L130220_014_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130220_014_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-140	Homo sapiens	blood plasma	not applicable	not applicable	72	female	70	35	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	70	run 140	proteomic profiling by mass spectrometry	yanliu_L130109_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_003_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-141	Homo sapiens	blood plasma	not applicable	not applicable	75	female	71	36	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	71	run 141	proteomic profiling by mass spectrometry	yanliu_L130308_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_002_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-142	Homo sapiens	blood plasma	not applicable	not applicable	64	female	71	36	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	71	run 142	proteomic profiling by mass spectrometry	yanliu_L130124_023_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_023_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-143	Homo sapiens	blood plasma	not applicable	not applicable	70	female	72	36	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	72	run 143	proteomic profiling by mass spectrometry	yanliu_L130109_033_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_033_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-144	Homo sapiens	blood plasma	not applicable	not applicable	64	female	72	36	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	72	run 144	proteomic profiling by mass spectrometry	yanliu_L130109_007_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_007_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-145	Homo sapiens	blood plasma	not applicable	not applicable	70	female	73	37	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	73	run 145	proteomic profiling by mass spectrometry	yanliu_L130109_034_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_034_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-146	Homo sapiens	blood plasma	not applicable	not applicable	72	female	73	37	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	73	run 146	proteomic profiling by mass spectrometry	yanliu_L130308_016_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_016_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-147	Homo sapiens	blood plasma	not applicable	not applicable	75	female	74	37	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	74	run 147	proteomic profiling by mass spectrometry	yanliu_L130308_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_003_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-148	Homo sapiens	blood plasma	not applicable	not applicable	72	female	74	37	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	74	run 148	proteomic profiling by mass spectrometry	yanliu_L130308_017_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_017_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-149	Homo sapiens	blood plasma	not applicable	not applicable	75	female	75	38	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	75	run 149	proteomic profiling by mass spectrometry	yanliu_L130308_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_006_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-150	Homo sapiens	blood plasma	not applicable	not applicable	51	female	75	38	dizygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	75	run 150	proteomic profiling by mass spectrometry	yanliu_L130308_008_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_008_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-151	Homo sapiens	blood plasma	not applicable	not applicable	58	female	76	38	dizygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	76	run 151	proteomic profiling by mass spectrometry	yanliu_L130220_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130220_006_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-152	Homo sapiens	blood plasma	not applicable	not applicable	51	female	76	38	dizygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	76	run 152	proteomic profiling by mass spectrometry	yanliu_L130308_009_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_009_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-153	Homo sapiens	blood plasma	not applicable	not applicable	58	female	77	39	dizygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	77	run 153	proteomic profiling by mass spectrometry	yanliu_L130116_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_006_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-154	Homo sapiens	blood plasma	not applicable	not applicable	59	female	77	39	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	77	run 154	proteomic profiling by mass spectrometry	yanliu_L130313_014_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_014_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-155	Homo sapiens	blood plasma	not applicable	not applicable	66	female	78	39	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	78	run 155	proteomic profiling by mass spectrometry	yanliu_L130109_038_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_038_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-156	Homo sapiens	blood plasma	not applicable	not applicable	59	female	78	39	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	78	run 156	proteomic profiling by mass spectrometry	yanliu_L130313_017_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_017_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-157	Homo sapiens	blood plasma	not applicable	not applicable	66	female	79	40	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	79	run 157	proteomic profiling by mass spectrometry	yanliu_L130109_039_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_039_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-158	Homo sapiens	blood plasma	not applicable	not applicable	57	female	79	40	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	79	run 158	proteomic profiling by mass spectrometry	yanliu_L130116_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_002_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-159	Homo sapiens	blood plasma	not applicable	not applicable	62	female	80	40	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	80	run 159	proteomic profiling by mass spectrometry	yanliu_L130211_012_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_012_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-160	Homo sapiens	blood plasma	not applicable	not applicable	57	female	80	40	dizygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	80	run 160	proteomic profiling by mass spectrometry	yanliu_L130220_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130220_003_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-161	Homo sapiens	blood plasma	not applicable	not applicable	62	female	81	41	dizygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	81	run 161	proteomic profiling by mass spectrometry	yanliu_L130109_027_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_027_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-162	Homo sapiens	blood plasma	not applicable	not applicable	71	female	81	41	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	81	run 162	proteomic profiling by mass spectrometry	yanliu_L130104_029_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_029_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-163	Homo sapiens	blood plasma	not applicable	not applicable	73	female	82	41	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	82	run 163	proteomic profiling by mass spectrometry	yanliu_L130124_002_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_002_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-164	Homo sapiens	blood plasma	not applicable	not applicable	71	female	82	41	dizygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	82	run 164	proteomic profiling by mass spectrometry	yanliu_L130104_030_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_030_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-165	Homo sapiens	blood plasma	not applicable	not applicable	73	female	83	42	dizygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	83	run 165	proteomic profiling by mass spectrometry	yanliu_L130124_012_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_012_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-166	Homo sapiens	blood plasma	not applicable	not applicable	53	female	83	42	dizygotic	not applicable	normal	"N.A. at visit 1, Going through menopause or Post menopausal reported at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	83	run 166	proteomic profiling by mass spectrometry	yanliu_L130124_019_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_019_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-167	Homo sapiens	blood plasma	not applicable	not applicable	60	female	84	42	dizygotic	not applicable	normal	"N.A. at visit 1, Going through menopause or Post menopausal reported at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	84	run 167	proteomic profiling by mass spectrometry	yanliu_L130116_007_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_007_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-168	Homo sapiens	blood plasma	not applicable	not applicable	60	female	84	42	dizygotic	not applicable	normal	"N.A. at visit 1, Going through menopause or Post menopausal reported at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	84	run 168	proteomic profiling by mass spectrometry	yanliu_L130116_041_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_041_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-169	Homo sapiens	blood plasma	not applicable	not applicable	53	female	85	43	dizygotic	not applicable	normal	"N.A. at visit 1, Going through menopause or Post menopausal reported at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	85	run 169	proteomic profiling by mass spectrometry	yanliu_L130308_020_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_020_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-170	Homo sapiens	blood plasma	not applicable	not applicable	60	female	85	43	dizygotic	not applicable	normal	"N.A. at visit 1, Going through menopause or Post menopausal reported at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	85	run 170	proteomic profiling by mass spectrometry	yanliu_L130220_009_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130220_009_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-171	Homo sapiens	blood plasma	not applicable	not applicable	53	female	86	43	dizygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	86	run 171	proteomic profiling by mass spectrometry	yanliu_L130313_037_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_037_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-172	Homo sapiens	blood plasma	not applicable	not applicable	60	female	86	43	dizygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	86	run 172	proteomic profiling by mass spectrometry	yanliu_L130319_012_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_012_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-173	Homo sapiens	blood plasma	not applicable	not applicable	53	female	87	44	dizygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	87	run 173	proteomic profiling by mass spectrometry	yanliu_L130109_022_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_022_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-174	Homo sapiens	blood plasma	not applicable	not applicable	60	female	87	44	dizygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	87	run 174	proteomic profiling by mass spectrometry	yanliu_L130116_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_003_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-175	Homo sapiens	blood plasma	not applicable	not applicable	70	female	88	44	monozygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	88	run 175	proteomic profiling by mass spectrometry	yanliu_L130211_022_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_022_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-176	Homo sapiens	blood plasma	not applicable	not applicable	75	female	88	44	monozygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	88	run 176	proteomic profiling by mass spectrometry	yanliu_L130109_015_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_015_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-177	Homo sapiens	blood plasma	not applicable	not applicable	70	female	89	45	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	89	run 177	proteomic profiling by mass spectrometry	yanliu_L130319_001_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_001_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-178	Homo sapiens	blood plasma	not applicable	not applicable	75	female	89	45	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	89	run 178	proteomic profiling by mass spectrometry	yanliu_L130109_016_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_016_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-179	Homo sapiens	blood plasma	not applicable	not applicable	64	female	90	45	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	90	run 179	proteomic profiling by mass spectrometry	yanliu_L130109_013_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_013_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-180	Homo sapiens	blood plasma	not applicable	not applicable	70	female	90	45	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	90	run 180	proteomic profiling by mass spectrometry	yanliu_L130124_025_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_025_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-181	Homo sapiens	blood plasma	not applicable	not applicable	64	female	91	46	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	91	run 181	proteomic profiling by mass spectrometry	yanliu_L130109_014_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_014_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-182	Homo sapiens	blood plasma	not applicable	not applicable	70	female	91	46	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	91	run 182	proteomic profiling by mass spectrometry	yanliu_L130109_008_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_008_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-183	Homo sapiens	blood plasma	not applicable	not applicable	58	female	92	46	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	92	run 183	proteomic profiling by mass spectrometry	yanliu_L130308_012_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_012_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-184	Homo sapiens	blood plasma	not applicable	not applicable	65	female	92	46	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	92	run 184	proteomic profiling by mass spectrometry	yanliu_L130109_029_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_029_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-185	Homo sapiens	blood plasma	not applicable	not applicable	58	female	93	47	monozygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	93	run 185	proteomic profiling by mass spectrometry	yanliu_L130308_013_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_013_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-186	Homo sapiens	blood plasma	not applicable	not applicable	65	female	93	47	monozygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	93	run 186	proteomic profiling by mass spectrometry	yanliu_L130109_030_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_030_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-187	Homo sapiens	blood plasma	not applicable	not applicable	55	female	94	47	monozygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	94	run 187	proteomic profiling by mass spectrometry	yanliu_L130313_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_005_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-188	Homo sapiens	blood plasma	not applicable	not applicable	61	female	94	47	monozygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	94	run 188	proteomic profiling by mass spectrometry	yanliu_L130313_016_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_016_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-189	Homo sapiens	blood plasma	not applicable	not applicable	55	female	95	48	monozygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	95	run 189	proteomic profiling by mass spectrometry	yanliu_L130313_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_006_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-190	Homo sapiens	blood plasma	not applicable	not applicable	61	female	95	48	monozygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	95	run 190	proteomic profiling by mass spectrometry	yanliu_L130313_019_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_019_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-191	Homo sapiens	blood plasma	not applicable	not applicable	59	female	96	48	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	96	run 191	proteomic profiling by mass spectrometry	yanliu_L130313_026_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_026_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-192	Homo sapiens	blood plasma	not applicable	not applicable	65	female	96	48	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	96	run 192	proteomic profiling by mass spectrometry	yanliu_L130211_008_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_008_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-193	Homo sapiens	blood plasma	not applicable	not applicable	59	female	97	49	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	97	run 193	proteomic profiling by mass spectrometry	yanliu_L130313_029_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_029_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-194	Homo sapiens	blood plasma	not applicable	not applicable	65	female	97	49	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	97	run 194	proteomic profiling by mass spectrometry	yanliu_L130211_016_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_016_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-195	Homo sapiens	blood plasma	not applicable	not applicable	64	female	98	49	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	98	run 195	proteomic profiling by mass spectrometry	yanliu_L130211_017_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_017_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-196	Homo sapiens	blood plasma	not applicable	not applicable	69	female	98	49	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	98	run 196	proteomic profiling by mass spectrometry	yanliu_L130211_007_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_007_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-197	Homo sapiens	blood plasma	not applicable	not applicable	64	female	99	50	monozygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	99	run 197	proteomic profiling by mass spectrometry	yanliu_L130211_018_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_018_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-198	Homo sapiens	blood plasma	not applicable	not applicable	69	female	99	50	monozygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	99	run 198	proteomic profiling by mass spectrometry	yanliu_L130313_015_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_015_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-199	Homo sapiens	blood plasma	not applicable	not applicable	71	female	100	50	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	100	run 199	proteomic profiling by mass spectrometry	yanliu_L130220_011_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130220_011_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-200	Homo sapiens	blood plasma	not applicable	not applicable	78	female	100	50	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	100	run 200	proteomic profiling by mass spectrometry	yanliu_L130308_031_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_031_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-201	Homo sapiens	blood plasma	not applicable	not applicable	71	female	101	51	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	101	run 201	proteomic profiling by mass spectrometry	yanliu_L130220_012_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130220_012_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-202	Homo sapiens	blood plasma	not applicable	not applicable	78	female	101	51	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	101	run 202	proteomic profiling by mass spectrometry	yanliu_L130109_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_005_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-203	Homo sapiens	blood plasma	not applicable	not applicable	41	female	102	51	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	102	run 203	proteomic profiling by mass spectrometry	yanliu_L130211_014_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_014_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-204	Homo sapiens	blood plasma	not applicable	not applicable	46	female	102	51	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	102	run 204	proteomic profiling by mass spectrometry	yanliu_L130109_040_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_040_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-205	Homo sapiens	blood plasma	not applicable	not applicable	41	female	103	52	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	103	run 205	proteomic profiling by mass spectrometry	yanliu_L130313_025_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_025_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-206	Homo sapiens	blood plasma	not applicable	not applicable	46	female	103	52	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	103	run 206	proteomic profiling by mass spectrometry	yanliu_L130124_024_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_024_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-207	Homo sapiens	blood plasma	not applicable	not applicable	52	female	104	52	monozygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	104	run 207	proteomic profiling by mass spectrometry	yanliu_L130116_019_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_019_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-208	Homo sapiens	blood plasma	not applicable	not applicable	56	female	104	52	monozygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	104	run 208	proteomic profiling by mass spectrometry	yanliu_L130308_007_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_007_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-209	Homo sapiens	blood plasma	not applicable	not applicable	52	female	105	53	monozygotic	not applicable	normal	"Going through menopause at visit 1, Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	105	run 209	proteomic profiling by mass spectrometry	yanliu_L130104_007_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_007_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-210	Homo sapiens	blood plasma	not applicable	not applicable	56	female	105	53	monozygotic	not applicable	normal	"Going through menopause at visit 1, Post menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	105	run 210	proteomic profiling by mass spectrometry	yanliu_L130319_016_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_016_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-211	Homo sapiens	blood plasma	not applicable	not applicable	61	female	106	53	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	106	run 211	proteomic profiling by mass spectrometry	yanliu_L130319_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_006_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-212	Homo sapiens	blood plasma	not applicable	not applicable	65	female	106	53	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	106	run 212	proteomic profiling by mass spectrometry	yanliu_L130104_032_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_032_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-213	Homo sapiens	blood plasma	not applicable	not applicable	61	female	107	54	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	107	run 213	proteomic profiling by mass spectrometry	yanliu_L130319_009_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130319_009_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-214	Homo sapiens	blood plasma	not applicable	not applicable	65	female	107	54	monozygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	107	run 214	proteomic profiling by mass spectrometry	yanliu_L130104_033_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_033_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-215	Homo sapiens	blood plasma	not applicable	not applicable	40	female	108	54	monozygotic	not applicable	normal	"N.A. at visit 1,Pre menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	108	run 215	proteomic profiling by mass spectrometry	yanliu_L130116_010_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_010_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-216	Homo sapiens	blood plasma	not applicable	not applicable	45	female	108	54	monozygotic	not applicable	normal	"N.A. at visit 1,Pre menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	108	run 216	proteomic profiling by mass spectrometry	yanliu_L130308_014_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_014_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-217	Homo sapiens	blood plasma	not applicable	not applicable	40	female	109	55	monozygotic	not applicable	normal	"N.A. at visit 1, Pre menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	109	run 217	proteomic profiling by mass spectrometry	yanliu_L130116_042_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_042_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-218	Homo sapiens	blood plasma	not applicable	not applicable	45	female	109	55	monozygotic	not applicable	normal	"N.A. at visit 1, Pre menopausal at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	109	run 218	proteomic profiling by mass spectrometry	yanliu_L130308_015_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130308_015_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-219	Homo sapiens	blood plasma	not applicable	not applicable	64	female	110	55	monozygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	110	run 219	proteomic profiling by mass spectrometry	yanliu_L130124_026_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_026_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-220	Homo sapiens	blood plasma	not applicable	not applicable	70	female	110	55	monozygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	110	run 220	proteomic profiling by mass spectrometry	yanliu_L130313_003_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_003_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-221	Homo sapiens	blood plasma	not applicable	not applicable	64	female	111	56	monozygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	111	run 221	proteomic profiling by mass spectrometry	yanliu_L130124_027_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_027_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-222	Homo sapiens	blood plasma	not applicable	not applicable	70	female	111	56	monozygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	111	run 222	proteomic profiling by mass spectrometry	yanliu_L130313_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_004_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-223	Homo sapiens	blood plasma	not applicable	not applicable	60	female	112	56	dizygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	112	run 223	proteomic profiling by mass spectrometry	yanliu_L130211_006_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_006_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-224	Homo sapiens	blood plasma	not applicable	not applicable	67	female	112	56	dizygotic	not applicable	normal	"Going through menopause at visit 1, N,A, at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	112	run 224	proteomic profiling by mass spectrometry	yanliu_L130104_034_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_034_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-225	Homo sapiens	blood plasma	not applicable	not applicable	60	female	113	57	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	113	run 225	proteomic profiling by mass spectrometry	yanliu_L130313_013_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130313_013_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-226	Homo sapiens	blood plasma	not applicable	not applicable	67	female	113	57	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	113	run 226	proteomic profiling by mass spectrometry	yanliu_L130104_035_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_035_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-227	Homo sapiens	blood plasma	not applicable	not applicable	58	female	114	57	dizygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	114	run 227	proteomic profiling by mass spectrometry	yanliu_L130109_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_004_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-228	Homo sapiens	blood plasma	not applicable	not applicable	65	female	114	57	dizygotic	not applicable	normal	"N.A. at visit 1, N.A.  at visit 2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	114	run 228	proteomic profiling by mass spectrometry	yanliu_L130104_024_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_024_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-229	Homo sapiens	blood plasma	not applicable	not applicable	58	female	115	58	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	115	run 229	proteomic profiling by mass spectrometry	yanliu_L130124_022_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130124_022_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-230	Homo sapiens	blood plasma	not applicable	not applicable	65	female	115	58	dizygotic	not applicable	normal	Post menopausal before visit 1	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	115	run 230	proteomic profiling by mass spectrometry	yanliu_L130104_025_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130104_025_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-231	Homo sapiens	blood plasma	not applicable	not applicable	41	female	116	58	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	116	run 231	proteomic profiling by mass spectrometry	yanliu_L130109_017_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130109_017_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-232	Homo sapiens	blood plasma	not applicable	not applicable	48	female	116	58	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	116	run 232	proteomic profiling by mass spectrometry	yanliu_L130116_004_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130116_004_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-233	Homo sapiens	blood plasma	not applicable	not applicable	41	female	117	59	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	117	run 233	proteomic profiling by mass spectrometry	yanliu_L130211_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130211_005_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
PXD001064-Sample-234	Homo sapiens	blood plasma	not applicable	not applicable	48	female	117	59	monozygotic	not applicable	normal	"Pre menopausal at visit 1, N.A. at visit2"	depleted	Top 14  (multiple affinity removal system MARS Hu-14 spin cartridge; Agilent Technologies)	117	run 234	proteomic profiling by mass spectrometry	yanliu_L130220_005_SW.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2015/01/PXD001064/yanliu_L130220_005_SW.wiff	1	NT=Data-Independent Acquisition;AC=PRIDE:0000450	AC=MS:1002038;NT=label free sample	1	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	AC=MS:1000932;NT=TripleTOF 5600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	not available	50 ppm	0.5 Da	blood plasma
